Resistance to targeted therapies in breast cancer
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...
Saved in:
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Cham, Switzerland :
Springer,
[2017]
|
Series: | Resistance to targeted anti-cancer therapeutics ;
v. 16. |
Subjects: | |
ISBN: | 9783319701424 9783319701417 |
Physical Description: | 1 online resource |
Online Access:
Online Resources